CD34+ cell subclasses and lymphocyte subsets in blood grafts collected after various mobilization methods in myeloma patients
Transfusion, 08/17/2012
Varmavuo V et al. – Plerixafor appears to have effects on blood stem cell graft composition in myeloma patients. A higher number of grafts should be evaluated in regard to cellular content and longer follow–up of the patients is needed to evaluate the potential clinical impact of graft content.



